Cancer News and Research

Latest Cancer News and Research

New discovery of adult stem cells gives fresh possibilities for heart regeneration

Sydney researchers have discovered a new population of adult stem cells in the heart, which could augment the development of new regeneration and repair therapies for people who have suffered heart attack or heart failure, the leading cause of death in Australia.

1 Dec 2011

Study presents high-resolution genome-wide p53-binding map for normal human cells

Scientists investigating the interactions, or binding patterns, of a major tumor-suppressor protein known as p53 with the entire genome in normal human cells have turned up key differences from those observed in cancer cells. The distinct binding patterns reflect differences in the chromatin (the way DNA is packed with proteins), which may be important for understanding the function of the tumor suppressor protein in cancer cells.

1 Dec 2011

Study reveals no clear advantage of one implant type over another

More than 270,000 Americans get hip replacement surgeries every year -- a number that is projected to double in the next decade as the population ages. With various options for implants, including metal-on-polyethylene, metal-on-metal and ceramic-on-ceramic, there have been questions about which kind works best.

1 Dec 2011

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Speaking today at the plenary session of the 7th Annual European Antibody Congress in Geneva, Dr. Anat Cohen-Dayag, President and CEO of Compugen Ltd., presented Compugen's Antibody Target Discovery Platform, one of the Company's predictive discovery platforms for novel therapeutic targets.

1 Dec 2011

Cancer researchers create catalog of possible targets for new treatments

As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments.

1 Dec 2011

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound.

1 Dec 2011

First neurovascular unit opens at Krembil Neuroscience Centre

The first neurovascular unit (NVU) in Canada opened today at the Krembil Neuroscience Centre, Toronto Western Hospital, which is part of the University Health Network.

1 Dec 2011

Onconova uses BioClinica EDC, data management services to support clinical trials

BioClinica, Inc., a global provider of clinical trial management solutions, today announced that Onconova Therapeutics, Inc. has extended agreements using BioClinica Express electronic data capture (EDC) and data management services to support their clinical trials world-wide.

From Clario 1 Dec 2011

arGEN-X closes EUR 27.5 million Series B fundraising round

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today the closing of a EUR 27.5 million (USD 37 million) Series B fundraising round, which was oversubscribed.

1 Dec 2011

Santaris Pharma wins two LNA patent re-examination cases in the U.S.

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.

1 Dec 2011

Viewpoints: Entrenchment on Capitol Hill; Medicaid's woes; Presidential mistake on Berwick

Last week's failure of the budget super committee, despite its super powers, is only the latest breakdown in an attempt at compromise in Washington. Politicians keep trying to fashion failsafe solutions to the capital's uncompromising mind-set, without understanding that there is no external escape from an environment that rewards those who stand tenaciously on their principles and demonize their opponents. Members of Congress need to change their minds about compromise, or voters will need to change the members of Congress.

1 Dec 2011

Harvard SEAS, BASF to co-host symposium on pharmaceutical nanoformulations

From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.

1 Dec 2011

Idera regains global rights to IMO-2055 from Merck KGaA for treatment of cancer

Idera Pharmaceuticals, Inc. today announced that it has regained global rights to IMO-2055, an agonist of Toll-like Receptor (TLR) 9, as part of an agreed-upon termination of its oncology collaboration with Merck KGaA, Darmstadt, Germany.

1 Dec 2011

Hospice family caregivers require unique care needs

A study led by the University of Kentucky researcher Elaine Wittenberg-Lyles found that hospice family caregivers are "second order patients" themselves and require their own unique care needs.

1 Dec 2011

Potential test to diagnose membranous nephropathy in early stages

Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) has led to the development of a test that can help diagnose membranous nephropathy in its early stages.

1 Dec 2011

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.

1 Dec 2011

Oral ingestion of apple polyphenols can prevent colitis in mice

Here's another reason why "an apple a day keeps the doctor away"-according to new research findings published in the Journal of Leukocyte Biology, oral ingestion of apple polyphenols can suppress T cell activation to prevent colitis in mice.

1 Dec 2011

Joslin study uncovers potential targets for soft-tissue sarcomas

Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop the growth of these often deadly tumors.

30 Nov 2011

Annual mammograms may be necessary beyond 40: Study

According to a latest study, women, even without family history of breast cancer, should undergo cancer screening or a mammography every year after reaching the age of 40.

30 Nov 2011

Morning snacking harms diet and affects weight loss efforts: Study

According to a new study snacking between breakfast and lunch might damage the diet more than snacking at other times of the day. Women taking part in a weight loss study who ate a midmorning snack lost an average of 7 percent of their body weight over the course of a year, whereas women who did not snack before lunch lost 11 percent of their body weight the study revealed.

30 Nov 2011

Cancer News and Research

Latest Cancer News and Research

New discovery of adult stem cells gives fresh possibilities for heart regeneration

Study presents high-resolution genome-wide p53-binding map for normal human cells

Study reveals no clear advantage of one implant type over another

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Cancer researchers create catalog of possible targets for new treatments

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

First neurovascular unit opens at Krembil Neuroscience Centre

Onconova uses BioClinica EDC, data management services to support clinical trials

arGEN-X closes EUR 27.5 million Series B fundraising round

Santaris Pharma wins two LNA patent re-examination cases in the U.S.

Viewpoints: Entrenchment on Capitol Hill; Medicaid's woes; Presidential mistake on Berwick

Harvard SEAS, BASF to co-host symposium on pharmaceutical nanoformulations

Idera regains global rights to IMO-2055 from Merck KGaA for treatment of cancer

Hospice family caregivers require unique care needs

Potential test to diagnose membranous nephropathy in early stages

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Oral ingestion of apple polyphenols can prevent colitis in mice

Joslin study uncovers potential targets for soft-tissue sarcomas

Annual mammograms may be necessary beyond 40: Study

Morning snacking harms diet and affects weight loss efforts: Study

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in